Tag: article

REYKJAVIK, ICELAND (June 18, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the closing on June 17, 2026 of its previously announced underwritten public offering (the “Offering”) of 26,066,667 of its ordinary shares at an offering price of $3.75 per share, which includes 3,400,000 ordinary shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional ordinary shares in the Offering. All ordinary shares sold in the Offering were offered by Alvotech. Before deducting the underwriting discounts and commissions and offering expenses, the aggregate gross proceeds to the Company were approximately $98 million.

PRESS RELEASE

AUSTIN, Texas, June 17, 2026 (GLOBE NEWSWIRE) -- via IBN -- IBN.Ai, a cutting-edge corporate communications and digital engagement platform, is marking its 20^th anniversary by reflecting on more than two decades of growth, innovation and service to the investment community while setting its sights on the  next phase of its evolution. Since its founding, IBN has grown from its roots as an investor-focused communications pioneer into a multifaceted organization delivering tailored platform solutions that help private and public companies amplify visibility, strengthen market recognition and engage diverse investor audiences.

Pursuant to the Market Abuse Regulation (EU) no. 596/2014, as amended, article 19, InstallatørGruppen A/S (“InstallatørGruppen”) hereby notifies receipt of information of the following transactions made by persons discharging managerial responsibilities in InstallatørGruppen and their closely associated persons in InstallatørGruppen’s shares.